[{"Assets_0_Q2_USD":17460310.0,"CommonStockSharesOutstanding_0_Q2_shares":24099951.0,"EarningsPerShareBasic_1_Q2_USD":-0.34,"EarningsPerShareBasic_2_Q2_USD":-1.16,"EarningsPerShareDiluted_2_Q2_USD":-1.16,"EarningsPerShareDiluted_1_Q2_USD":-0.38,"NetIncomeLoss_1_Q2_USD":-8044776.0,"NetIncomeLoss_2_Q2_USD":-27143598.0,"StockholdersEquity_0_Q2_USD":-26853811.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":23801223.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":23496197.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":23457361.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":23723551.0,"Ticker":"OTLK","CIK":"1649989","name":"ONCOBIOLOGICS, INC.","OfficialName":"Outlook Therapeutics Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"403697299.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170515"}]